Hester Biosciences (BOM:524669) E10: ₹46.73 (As of Mar. 2026)


BOM:524669 Hester Biosciences Ltd BOM:524669
79 GF Score
Price ₹2,163.15
GF Value ₹1,887.29
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Hester Biosciences E10?

Hester Biosciences BOM:524669 -2.07% 79 E10 is ₹46.73 as of Mar. 2026. GuruFocus rates BOM:524669 with a GF Score™ of 79/100 and a GF Value™ of ₹1,887.29 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hester Biosciences's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹19.450. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹46.73 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Hester Biosciences's average E10 Growth Rate was 12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-06), Hester Biosciences's current stock price is ₹2163.15. Hester Biosciences's E10 for the quarter that ended in Mar. 2026 was ₹46.73. Hester Biosciences's Shiller PE Ratio of today is 46.29.

During the past 13 years, the highest Shiller PE Ratio of Hester Biosciences was 76.73. The lowest was 29.34. And the median was 42.91.


Hester Biosciences  (BOM:524669) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hester Biosciences's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2163.15/46.73
=46.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Hester Biosciences was 76.73. The lowest was 29.34. And the median was 42.91.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hester Biosciences E10 Related Terms


Hester Biosciences E10 Historical Data

* Premium members only.

The historical data trend for Hester Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hester Biosciences E10 Chart

Hester Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 41.43 46.73

Hester Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.43 43.20 44.57 44.82 46.73

BOM:524669 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hester Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hester Biosciences Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hester Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hester Biosciences's Shiller PE Ratio falls into.


BOM:524669
79GF Score
Hester Biosciences Ltd BOM:524669
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hester Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hester Biosciences's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=19.45/164.2724*164.2724
=19.450

Current CPI (Mar. 2026) = 164.2724.

Hester Biosciences Quarterly Data

per share eps CPI Adj_EPS
201209 4.140 82.244 8.269
201212 3.250 83.774 6.373
201303 4.370 85.687 8.378
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 10.144 111.317 14.970
201809 8.198 115.142 11.696
201812 15.048 115.142 21.469
201903 15.475 118.202 21.507
201906 9.859 120.880 13.398
201909 7.669 123.175 10.228
201912 13.541 126.235 17.621
202003 3.222 124.705 4.244
202006 6.718 127.000 8.690
202009 7.850 130.118 9.911
202012 14.512 130.889 18.213
202103 11.388 131.771 14.197
202106 14.682 134.084 17.988
202109 13.080 135.847 15.817
202112 9.973 138.161 11.858
202203 9.079 138.822 10.743
202206 4.190 142.347 4.835
202209 7.770 144.661 8.823
202212 14.290 145.763 16.105
202303 5.061 146.865 5.661
202306 7.890 150.280 8.625
202309 4.803 151.492 5.208
202312 4.730 152.924 5.081
202403 4.844 153.035 5.200
202406 8.800 155.789 9.279
202409 9.860 157.882 10.259
202412 13.410 158.323 13.914
202503 1.820 157.552 1.898
202506 20.330 159.755 20.905
202509 16.850 162.289 17.056
202512 10.940 163.281 11.006
202603 19.450 164.272 19.450

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹46.73 mean?
Hester Biosciences (BOM:524669) has a E10 of ₹46.73 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hester Biosciences and its competitors.
Is Hester Biosciences' E10 too high?
Hester Biosciences' current E10 is ₹46.73. Overall, Hester Biosciences has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hester Biosciences' E10 compare to ZTS and UTHR?
Hester Biosciences' E10 of ₹46.73 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hester Biosciences and its competitors. Hester Biosciences's current E10 is ₹46.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hester Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Hester Biosciences (BOM:524669) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,887.29, compared to a current price of ₹2,163.15 — trading 14.6% above its estimated fair value. The current E10 is ₹46.73. Hester Biosciences' overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Hester Biosciences (BOM:524669), the current E10 is ₹46.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hester Biosciences (BOM:524669) Overvalued in 2026?

Based on GuruFocus' analysis, Hester Biosciences stock appears to be overvalued. The current stock price of ₹2,163.15 is trading 14.6% above its estimated GF Value™ of ₹1,887.29. GuruFocus considers Hester Biosciences to be Modestly Overvalued.

Key valuation signals for BOM:524669:

  • E10: ₹46.73
  • GF Value™: ₹1,887.29 vs. price of ₹2,163.15 (14.6% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the BOM:524669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hester Biosciences Business Description

Other Exchanges HESTERBIO:India
Address Village Meda - Adraj, Taluka Kadi, District Mehsana, Mehsana, GJ, IND, 384441
Hester Biosciences Ltd is an India-based animal healthcare company. It is principally engaged in the manufacturing of veterinary vaccines and trading of veterinary health products such as goat pox vaccine, PPR vaccines, etc. The group has two principal operating and reporting segments, viz. Poultry healthcare and Animal healthcare. Maximum revenue is generated from the Poultry Healthcare segment, which offers various solutions encompassing vaccines, health products, and feed supplements, supported and packaged by its diagnostic services, R&D, quality standards, and field support, to help farmers protect flock health, enhance productivity, and drive long-term farm sustainability. Geographically, it generates maximum revenue within India, and also exports its products to other markets.
79GF Score

Get the complete analysis for BOM:524669

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,163.15
Price
₹1,887.29
GF Value